OSILODROSTAT
osilodrostat 5 mg tablet, 60
OSILODROSTAT (14724Y)
14724Y
Manner of administration:Oral
Restriction
Indication: Endogenous Cushing's syndrome
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 6 | DPMQ: $9,822.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Isturisa | |||||